Also, the 50-gene PAM50 test was developed to discriminate breast cancer subtypes (Luminal A, Luminal B, HER2-Enriched and basal like) and generated a risk of recurrence score (ROR). This evidence concerns the gene ERBB2 and breast carcinoma.